-
2 Healthcare Dividend Stocks That are Just What the Doctor Ordered
04 Feb 2026 00:29 GMT
… sales for blockbuster drugs made by pharmaceutical companies decline … sustainable.
Medtronic: Diversified medical equipment maker sees steady … inside a pill that allows doctors to view inside … in its atrial fibrillation treatment and ambulatory surgery centers …
-
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q4 2025 Earnings Call Transcript
29 Jan 2026 13:46 GMT
… January 28, 2026
Teva Pharmaceutical Industries Limited beats earnings expectations … from oral therapies or treatment naive, which confirms that … understand that we have Medicaid and Medicare. And so we … s say, the classic biotech space rather than what’s …
-
Biosimilars Market to Reach US$86.2 Bn by 2032 at 13.9% CAGR: Persistence Market Research
02 Feb 2026 16:00 GMT
… major biologics. High-value drugs such as Humira (adalimumab), which previously … opportunities, stimulate competition, lower treatment costs, and encourage broader adoption … proactive adoption policies. The European Medicines Agency (EMA) has approved …
-
Regulatory tracker: AZ, Daiichi nab priority review tag as Datroway homes in on next FDA nod
02 Jan 2026 18:47 GMT
… ET
In Europe, Acadia Pharmaceuticals'; application for trofinetide … s drug won an FDA approval to become the first approved treatment … of any new clinical trials”, ImmunityBio said. The company … winning streak for the medicine, which recently picked up …
-
Alvotech enters supply and commercialization agreements for Canada and Australia & New Zealand covering multiple biosimilar candidates
02 Feb 2026 08:00 GMT
… biotechnology company specializing in the development and manufacture of biosimilar medicines … Alvotech
Alvotech is a biotechnology company, founded by Robert … global markets, including biosimilars to Humira® (adalimumab), Stelara® (ustekinumab), Simponi® …
-
How Big Pharma is navigating a $300 billion patent cliff
30 Jan 2026 13:37 GMT
… a strong pipeline of new medicines to offset the losses, … focus on cancer treatments, with 16 oncology drugs in its pipeline … LM-299 from LaNova Medicines. Other cancer drugs in its pipeline … better trajectory to withstand the Humira hit through deals with …
-
Robert Wachter: AI Is Already Remaking Healthcare
04 Feb 2026 00:21 GMT
… by saying, “Doctor, did you know that the best medicine for this … money if we give this drug and therefore that is going … in medicine, because I think you’re going to see most doctors … arthritis and you’re on Humira. It’s in the system …
-
<![CDATA[Round-Up: Every Most Favored Nation Agreement With the Trump Administration]]>
03 Feb 2026 18:36 GMT
… its approval from the FDA.4
Lilly will … Medicaid, while donating over 7 tons of apixaban’s active pharmaceutical … treatment and cure, at a discounted cash price. The drug … timolol maleate (Combigan), adalimumab (Humira), and levothyroxine sodium (Synthroid). …
-
Where Will AbbVie Be in 5 Years?
02 Feb 2026 11:10 GMT
… for both drugs continue to soar. The big biotech company … approaching the sales levels Humira achieved in its heyday. … for tavapadon for the treatment of Parkinson's … trials. Late-stage candidates to especially watch include the autoimmune disease drug …
-
Union Budget 26-27: FM Sitharaman’s ‘Biopharma SHAKTI’ signals India’s shift to innovation
01 Feb 2026 13:33 GMT
… 1,000 accredited clinical trial sites. Crucially, the … original drug, Humira, was the world’s highest-selling medicine, … frontier technologies.
The Indian Pharmaceutical Alliance (IPA) described … accessibility of life-saving treatments, bringing cutting-edge …